Acciones Beleave Inc. Canadian Securities Exchange
Acciones
BE
CA0775611084
Farmacéuticos
Ventas 2018 | - | Ventas 2019 | 2,37 3,24 2,2 | Capitalización | 30,37 M 41,49 M 28,12 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -12 M -16,4 M -11,11 M | Resultado Neto 2019 | -33 M -45,09 M -30,56 M | VE / Ventas 2018 | - |
Posición de caja neta 2018 | 5,2 M 7,11 M 4,82 M | Deuda neta 2019 | 10,32 M 14,09 M 9,55 M | VE / Ventas 2019 | 17.137.012 x |
P/E ratio 2018 |
-4,72
x | P/E ratio 2019 |
-0,76
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 98,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+43,17 % | 6287,15 M | |
-14,69 % | 4546,14 M | |
-8,17 % | 3228,59 M | |
+6,95 % | 3269,23 M | |
-1,76 % | 2555,44 M | |
+50,20 % | 2003,91 M | |
-7,85 % | 1683,21 M | |
-0,40 % | 1642,04 M | |
-9,91 % | 1586,73 M |